by Cryostem | Mar 18, 2022
Several CRYOSTEM players are participating in the 48th EBMT annual meeting. Here is a selection of posters and presentations that will be held as part of the scientific program: Dr. Eolia Brissot, member of the CRYOSTEM Scientific Committee: Monday, March 21, 09:00... 
by Cryostem | Oct 27, 2021
Rheos Medicines Forms Research Collaboration with CRYOSTEM to Evaluate MALT1 Targeted Therapeutics for Graft-versus-Host-Disease CAMBRIDGE, Mass., and MARSEILLE, France, October 27, 2021 – Rheos Medicines, a biopharmaceutical company bringing molecular targeting and... 
by Cryostem | Sep 27, 2021
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy. Marie Tourret, Nana Talvard-Balland, Marion Lambert, Ghada Ben Youssef, Mathieu F. Chevalier, Armelle Bohineust, Thomas Yvorra, Florence Morin,... 
by Cryostem | Sep 8, 2021
CRYOSTEM Scientific Day 2021 Under the aegis of SFGM-TC Amphithéâtre Millian, Hôpital Saint-Louis, Paris. This meeting will also be held in videoconference (access codes will be shared soon). Download the program — Call for abstracts (1 page, deadline Sep 30, 2021),... by Cryostem | Apr 27, 2021
Correlation between the recovery of certain innate immune lymphoid cells and the occurrence of GvHD after hematopoietic stem cell transplantation. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Piperoglou C, Larid... 